Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Jul;93(1):56–64. doi: 10.1111/j.1365-2249.1993.tb06497.x

Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.

K Broliden 1, E Sievers 1, P A Tovo 1, V Moschese 1, G Scarlatti 1, P A Broliden 1, C Fundaro 1, P Rossi 1
PMCID: PMC1554739  PMID: 8324904

Abstract

The prognostic and protective role of antibodies mediating cellular cytotoxicity (ADCC) and neutralization was evaluated in sera of HIV-1-infected mothers and their consecutively followed children. The presence and titres of ADCC mediating and/or neutralizing antibodies in maternal sera did not predict HIV-1 infection in their respective children. No significant difference in the sera from the children was seen when comparing the presence of neutralizing antibodies between the uninfected and infected children. Stratification of the infected group according to clinical status revealed differences. Only one of 24 AIDS patients had a high neutralizing titre against IIIB. Four patients had a very low titre and the remaining had no detectable neutralizing antibodies at all. In contrast, 10/17 infected non-AIDS children had neutralizing antibodies. Similarly, no significant difference was seen when comparing the presence of ADCC-mediating antibodies between the uninfected and the infected group of children. However, a significantly higher frequency of ADCC was seen in the seropositive non-AIDS children compared with the AIDS children. This study clearly shows that the presence of antibodies mediating ADCC and neutralization in infected children, 0-2 years old, is associated with a better clinical status and delayed disease progression.

Full text

PDF
56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg R. S., Paradis T., Hartshorn K. L., Vogt M., Ho D. D., Hirsch M. S., Leban J., Sato V. L., Schooley R. T. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. J Infect Dis. 1987 Dec;156(6):878–884. doi: 10.1093/infdis/156.6.878. [DOI] [PubMed] [Google Scholar]
  2. Broliden P. A., von Gegerfelt A., Clapham P., Rosen J., Fenyö E. M., Wahren B., Broliden K. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461–465. doi: 10.1073/pnas.89.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep. 1987 Apr 24;36(15):225-30, 235-6. [PubMed] [Google Scholar]
  4. Courgnaud V., Lauré F., Brossard A., Bignozzi C., Goudeau A., Barin F., Bréchot C. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses. 1991 Mar;7(3):337–341. doi: 10.1089/aid.1991.7.337. [DOI] [PubMed] [Google Scholar]
  5. Dalgleish A., Sinclair A., Steel M., Beatson D., Ludlam C., Habeshaw J. Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort. Clin Exp Immunol. 1990 Jul;81(1):5–10. doi: 10.1111/j.1365-2249.1990.tb05283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Devash Y., Calvelli T. A., Wood D. G., Reagan K. J., Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A. 1990 May;87(9):3445–3449. doi: 10.1073/pnas.87.9.3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ehrnst A., Lindgren S., Dictor M., Johansson B., Sönnerborg A., Czajkowski J., Sundin G., Bohlin A. B. HIV in pregnant women and their offspring: evidence for late transmission. Lancet. 1991 Jul 27;338(8761):203–207. doi: 10.1016/0140-6736(91)90347-r. [DOI] [PubMed] [Google Scholar]
  8. Gloeb D. J., O'Sullivan M. J., Efantis J. Human immunodeficiency virus infection in women. I. The effects of human immunodeficiency virus on pregnancy. Am J Obstet Gynecol. 1988 Sep;159(3):756–761. doi: 10.1016/s0002-9378(88)80049-8. [DOI] [PubMed] [Google Scholar]
  9. Johnstone F. D., MacCallum L., Brettle R., Inglis J. M., Peutherer J. F. Does infection with HIV affect the outcome of pregnancy? Br Med J (Clin Res Ed) 1988 Feb 13;296(6620):467–467. doi: 10.1136/bmj.296.6620.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kohl S., Strynadka N. C., Hodges R. S., Pereira L. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest. 1990 Jul;86(1):273–278. doi: 10.1172/JCI114695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lapointe N., Michaud J., Pekovic D., Chausseau J. P., Dupuy J. M. Transplacental transmission of HTLV-III virus. N Engl J Med. 1985 May 16;312(20):1325–1326. doi: 10.1056/NEJM198505163122012. [DOI] [PubMed] [Google Scholar]
  12. Lepage P., Van de Perre P., Caraël M., Nsengumuremyi F., Nkurunziza J., Butzler J. P., Sprecher S. Postnatal transmission of HIV from mother to child. Lancet. 1987 Aug 15;2(8555):400–400. doi: 10.1016/s0140-6736(87)92423-8. [DOI] [PubMed] [Google Scholar]
  13. Ljunggren K., Böttiger B., Biberfeld G., Karlson A., Fenyö E. M., Jondal M. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol. 1987 Oct 1;139(7):2263–2267. [PubMed] [Google Scholar]
  14. Ljunggren K., Moschese V., Broliden P. A., Giaquinto C., Quinti I., Fenyö E. M., Wahren B., Rossi P., Jondal M. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis. 1990 Feb;161(2):198–202. doi: 10.1093/infdis/161.2.198. [DOI] [PubMed] [Google Scholar]
  15. Maury W., Potts B. J., Rabson A. B. HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis. 1989 Oct;160(4):583–588. doi: 10.1093/infdis/160.4.583. [DOI] [PubMed] [Google Scholar]
  16. McKeating J. A., Gow J., Goudsmit J., Pearl L. H., Mulder C., Weiss R. A. Characterization of HIV-1 neutralization escape mutants. AIDS. 1989 Dec;3(12):777–784. doi: 10.1097/00002030-198912000-00001. [DOI] [PubMed] [Google Scholar]
  17. Nara P. L., Smit L., Dunlop N., Hatch W., Merges M., Waters D., Kelliher J., Gallo R. C., Fischinger P. J., Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol. 1990 Aug;64(8):3779–3791. doi: 10.1128/jvi.64.8.3779-3791.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
  19. Poulsen A. G., Kvinesdal B., Aaby P., Mølbak K., Frederiksen K., Dias F., Lauritzen E. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet. 1989 Apr 15;1(8642):827–831. doi: 10.1016/s0140-6736(89)92281-2. [DOI] [PubMed] [Google Scholar]
  20. Robert-Guroff M., Brown M., Gallo R. C. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature. 1985 Jul 4;316(6023):72–74. doi: 10.1038/316072a0. [DOI] [PubMed] [Google Scholar]
  21. Robert-Guroff M., Oleske J. M., Connor E. M., Epstein L. G., Minnefor A. B., Gallo R. C. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases. Pediatr Res. 1987 Jun;21(6):547–550. doi: 10.1203/00006450-198706000-00008. [DOI] [PubMed] [Google Scholar]
  22. Rogers M. F., Ou C. Y., Rayfield M., Thomas P. A., Schoenbaum E. E., Abrams E., Krasinski K., Selwyn P. A., Moore J., Kaul A. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med. 1989 Jun 22;320(25):1649–1654. doi: 10.1056/NEJM198906223202503. [DOI] [PubMed] [Google Scholar]
  23. Rossi P., Moschese V., Broliden P. A., Fundaró C., Quinti I., Plebani A., Giaquinto C., Tovo P. A., Ljunggren K., Rosen J. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8055–8058. doi: 10.1073/pnas.86.20.8055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Satow Y., Hashido M., Ishikawa K., Honda H., Mizuno M., Kawana T., Hayami M. Detection of HTLV-I antigen in peripheral and cord blood lymphocytes from carrier mothers. Lancet. 1991 Oct 12;338(8772):915–916. doi: 10.1016/0140-6736(91)91775-p. [DOI] [PubMed] [Google Scholar]
  25. Scott G. B., Hutto C., Makuch R. W., Mastrucci M. T., O'Connor T., Mitchell C. D., Trapido E. J., Parks W. P. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med. 1989 Dec 28;321(26):1791–1796. doi: 10.1056/NEJM198912283212604. [DOI] [PubMed] [Google Scholar]
  26. Seto M., Takahashi T., Nakamura S., Matsudaira Y., Nishizuka Y. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res. 1983 Oct;43(10):4768–4773. [PubMed] [Google Scholar]
  27. Shore S. L., Milgrom H., Wood P. A., Nahmias A. J. Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: functional adequacy in the neonate. Pediatrics. 1977 Jan;59(1):22–28. [PubMed] [Google Scholar]
  28. Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945–949. doi: 10.1056/NEJM198204223061601. [DOI] [PubMed] [Google Scholar]
  29. Steimer K. S., Scandella C. J., Skiles P. V., Haigwood N. L. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science. 1991 Oct 4;254(5028):105–108. doi: 10.1126/science.1718036. [DOI] [PubMed] [Google Scholar]
  30. Sundqvist V. A., Albert J., Ohlsson E., Hinkula J., Fenyö E. M., Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol. 1989 Nov;29(3):170–175. doi: 10.1002/jmv.1890290305. [DOI] [PubMed] [Google Scholar]
  31. Szelc C. M., Mitcheltree C., Roberts R. L., Stiehm E. R. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. J Infect Dis. 1992 Sep;166(3):486–493. doi: 10.1093/infdis/166.3.486. [DOI] [PubMed] [Google Scholar]
  32. Tovo P. A., Palomba E., Gabiano C., Galli L., de Martino M. Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol. 1991 Sep;98(9):940–942. doi: 10.1111/j.1471-0528.1991.tb13520.x. [DOI] [PubMed] [Google Scholar]
  33. Van de Peere P., Lepage P., Simonon A., Desgranges C., Hitimana D. G., Bazubagira A., Van Goethem C., Kleinschmidt A., Bex F., Broliden K. Biological markers associated with prolonged survival in African children maternally infected by the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1992 Apr;8(4):435–442. doi: 10.1089/aid.1992.8.435. [DOI] [PubMed] [Google Scholar]
  34. Weinhold K. J., Bolognesi D. P., Matthews T. J. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors. J Natl Cancer Inst. 1985 Oct;75(4):717–724. [PubMed] [Google Scholar]
  35. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C. A., Weller I. V., Tedder R. S. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature. 1985 Jul 4;316(6023):69–72. doi: 10.1038/316069a0. [DOI] [PubMed] [Google Scholar]
  36. Ziegler J. B., Cooper D. A., Johnson R. O., Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet. 1985 Apr 20;1(8434):896–898. doi: 10.1016/s0140-6736(85)91673-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES